Option chain shows key data for CNS Pharma's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for CNS Pharma.

CNS Pharma (NASDAQ:CNSP) Stock, Option Chain

CNS Pharmaceuticals

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Nasdaq index

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

CNSP

CRMD

DATS

FUFU

MURA

TNON

Nasdaq Gains 50 Points; US New Home Sales Rise In February

Genetic,Research,And,Biotech,Science,Concept.,Human,Biology,And,Pharmaceutical

Biotech

Health Care

Movers

General

CNS Pharmaceuticals&#39; Berubicin trial results show a favorable safety profile with no cardiotoxicity and comparable efficacy to Lomustine in recurrent GBM.

CNS Pharma&#39;s Cancer Drug Misses Survival Goal But May Offer Fewer Side Effects

WallStreet.Banks.Shutterstock

BACK

MULN

US Stocks Mixed; Core &amp; Main Posts Downbeat Earnings

CNS Pharmaceuticals Inc

Press Releases

CNS Pharmaceuticals Presents Update from Ongoing Potentially Pivotal Study of Berubicin Compared with Lomustine in Adult Patients with Recurrent GBM (WHO Grade IV) After Failure of Standard First Line Therapy

CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11, 2024

Events

CNS Pharmaceuticals to Present at the BIO CEO & Investor Conference

CNS Pharmaceuticals to Present at 6th Glioblastoma Drug Development Summit

CNS Pharmaceuticals Announces Reverse Stock Split

Virtual Investor "Top 5 for '25" Conference Hosted by JTC Now Available On-Demand

CNS Pharmaceuticals, Inc. Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference

CNS Pharmaceuticals to Present at the 18th Annual European Life Sciences CEO Forum

CNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ Listing

CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme

AKTX

AMIX

AREC

HURA

NVNO

OTLK

PALI

Akanda

Artelo Biosciences

CNS Pharma

Enveric Biosciences

Eyenovia

Hepion Pharmaceuticals, Inc. - Common Stock

Hepion Pharmaceuticals

Jaguar Health

NovaBay Pharmaceuticals, Inc. Common Stock

NovaBay Pharmaceuticals

Processa Pharmaceuticals, Inc. - Common Stock

Processa Pharmaceuticals

Petros Pharmaceuticals, Inc. - Common Stock

Petros Pharma

Redhill Biopharma Ltd. - American Depositary Shares

Redhill Biopharma

SenesTech

60 Degrees Pharmaceuticals, Inc. - Common Stock

60 Degrees

TNF Pharmaceuticals

Titan Pharmaceuticals, Inc. - Common Stock

Titan Pharma

Virpax Pharmaceuticals, Inc. - Common Stock

Virpax Pharmaceuticals

cbdMD

Screenshot 2024-02-26 at 8.44.39 PM

GBM, One Of The Deadliest Cancers, Could Have New Hope With Novel Drug

Comments

CNS Pharma

CNS Pharma (CNSP) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga